Physician profile
Preston B Wright
NPI 1306296496
$3,479.82
in general payments reported to CMS, 2019-2025
37 companies · $60.98 in 2025
The $60.98 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $726 · 2021: $1,427 · 2022: $867 · 2023: $97.43 · 2024: $65.83 · 2025: $60.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $224.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $391.61 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $294.51 | 2020-2022 | |
| Pfizer INC. | $278.44 | 2019-2022 | |
| Amgen INC. | $242.63 | 2019-2023 | Evenity, Prolia |
| Amarin Pharma, INC. | $182.14 | 2020-2022 | |
| Astellas Pharma US INC | $180.25 | 2020-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $171.02 | 2019-2021 | |
| Lilly USA, LLC | $165.69 | 2019-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $164.76 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $126.00 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $109.83 | 2022 | |
| Novo Nordisk INC | $98.66 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $98.64 | 2020-2021 | |
| Glaxosmithkline, LLC. | $91.41 | 2020-2023 | Trelegy Ellipta |
| Celgene Corporation | $86.80 | 2019 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $81.30 | 2020-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.62 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $68.26 | 2020-2022 | |
| Dexcom, INC. | $64.73 | 2021-2024 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $59.71 | 2022 | |
| Daiichi Sankyo INC. | $57.04 | 2020-2022 | |
| Esperion Therapeutics, INC. | $53.75 | 2021-2022 | |
| Abbott Laboratories | $45.94 | 2021-2023 | Freestyle Libre |
| Astrazeneca Pharmaceuticals LP | $39.94 | 2020-2021 | |
| Nestle Healthcare Nutrition INC. | $36.42 | 2021 | |
| Avanir Pharmaceuticals, INC. | $28.03 | 2022 | |
| Ardelyx, INC. | $23.17 | 2024 | Ibsrela |
| Xeris Pharmaceuticals, INC. | $23.07 | 2021 | |
| Allergan, INC. | $22.48 | 2019-2020 | |
| Biogen, INC. | $20.23 | 2021 | |
| Bausch Health US, LLC | $16.75 | 2022 | |
| Grt US Holding, INC. | $15.95 | 2021 | |
| Mylan Specialty L.P. | $14.60 | 2022 | |
| Eisai INC. | $13.85 | 2020 | |
| Genentech USA, INC. | $13.38 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.02 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preston Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.